A Nature study reports a single-molecule GLP-1–GIP–lanifibranor quintuple agonist that targets incretin receptor-expressing ...

Sophia Umansky—the 26-year-old daughter of Real Housewives of Beverly Hills' Kyle Richards and Mauricio Umansky—underwent a ...

NEARLY four million Britons have used weight-loss jabs such as Mounjaro or Wegovy, a survey suggests. One in every 14 is ...

A trial of 108 adults with obesity seeking treatment for alcohol use finds a once-weekly semaglutide injection reduced heavy ...

A landmark trial published in The Lancet has found that semaglutide — the active ingredient in Ozempic — reduced heavy ...

Weekly injection semaglutide - sold under brand names Wegovy and Ozempic - helped addicts cut number of heavy drinking days ...

Alcoholics given semaglutide reduced alcohol consumption, had fewer heavy drinking days and saw a reduction in alcohol ...

Eli Lilly said its tirzepatide franchise had another stellar quarter, with Mounjaro bringing in $8.7 billion in sales. Eli Lilly's GLP-1 franchise brought in a total of $12.9 billion in sales in the ...

Doctronic reports new AI analysis reveals GLP-1 medications may cause underreported symptoms like menstrual irregularities ...

Needles are soon to be a thing of the past. Eli Lilly’s new GLP-1 drug, Foundayo, received approval from the Food and Drug ...

A strong performance from Mounjaro overseas boosted Lilly’s results, and the company raised its guidance for the year for ...

Prescribing smaller GLP-1 receptor agonist doses could help users tolerate the drugs and lead to a more patient-centered ...